Formulary Monographs [DOXORUBICIN, 1000]
|
|
DOXORUBICIN
|
|
|
|
|
|
ANTINEOPLASTICS
|
|
|
Hodgkin's disease, non-Hodgkin's lymphomas, acute leukaemias.
|
|
|
Myelosuppression, reversible, alopecia, nausea, vomiting
|
|
|
60-75mg/M 2 i.v. as a single injection every 3 or 4 weeks; or 1.2-2.4 mg/kg once every 3 weeks.
|
|
|
|
|
|
Doxorubicin can cause fetal toxicity when administered to pregnant women, but potential benefits from use of the drug may be acceptable in certain conditions despite the possible risks to the fetus.
|
|
|
Not recommended.
|
|
|
|